Sometimes patients are so concerned with being good patients that they simply agree to what the clinician has said without fully understanding, and it's important to ask questions and ensure their voices are heard, said Mary Lou Smith, MBA, co-founder of the Research Advocacy Network.
Sometimes patients are so concerned with being good patients that they simply agree to what the clinician has said without fully understanding, and it's important to ask questions and ensure their voices are heard, said Mary Lou Smith, MBA, co-founder of the Research Advocacy Network.
Transcript (slightly modified for readability)
What ways can patients with cancer ensure that their voices are heard when it comes to treatment decisions for their care?
I think one of the most important things is to, as much as possible, take the emotion out of it. Sometimes when people get terribly emotional, people can't hear you. They get so distracted, either because you're raisiing your voice to them or they want to take care of you, but they're not hearing you. And I think that is the most important thing, is to be heard.
Being able to ask questions is almost important, and then get those questions answered fully. Sometimes we are trying to be good patients, and somebody, a doctor, says something to us, and we agree. We may not have gotten it at all, but we're trying to be good, because we want that person to take good care of us, so we want to be seen as a good patient.
With so much information available, what do you recommend for patients newly diagnosed with cancer so they don't feel overwhelmed?
There is so much information—some of it's good, some of it's bad. I think yo uhave to go to credible sources. Mayo has a good website with reviewed and researched answers. I think ASCO [American Society of Clinical Oncology] has a good website for patients. So it's at a level that most patients can understand or at least begin to understand.
I do think, for me anyway, there was nothing in the world that gave me more hope than talking to a woman who had breast cancer, who had survived it, and had a smile on her face and looked good. That made me hope that I could do that too.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More